Facial feminization surgery

I'm Dr. Alexandra Berges.

Today I'm joined by Dr. Daniel Knott from the University of California San Francisco, senior author of the research letter, Safety of Intraoperative Intravenous Tranexamic Acid Use in Facial Feminization Surgery Among Patients on Estrogen Supplementation.

Dr. Nott, thank you so much for joining us.

Dr. Burgess, thank you so much for the invitation.

It's great to be here.

So with this paper to start, we've heard a lot about TXA, and in recent years it's been applied to many surgical procedures to reduce blood loss and postoperative swelling.

Why did your team consider it an important question to study specifically in facial feminization surgery?

I-I-It's an interesting question because we began to focus on the avoidance of potential thromboembolism in our patients, and in fact, years before we conceived this project, we were facing our patients that were on high doses of estrogen supplementation.